127 related articles for article (PubMed ID: 31231865)
1. Access and concentrations of atorvastatin in the prostate in men with prostate cancer.
Knuuttila E; Riikonen J; Syvälä H; Auriola S; Murtola TJ
Prostate; 2019 Sep; 79(12):1412-1419. PubMed ID: 31231865
[TBL] [Abstract][Full Text] [Related]
2. Atorvastatin Versus Placebo for Prostate Cancer Before Radical Prostatectomy-A Randomized, Double-blind, Placebo-controlled Clinical Trial.
Murtola TJ; Syvälä H; Tolonen T; Helminen M; Riikonen J; Koskimäki J; Pakarainen T; Kaipia A; Isotalo T; Kujala P; Tammela TLJ
Eur Urol; 2018 Dec; 74(6):697-701. PubMed ID: 30031572
[TBL] [Abstract][Full Text] [Related]
3. Circulatory and prostatic tissue lipidomic profiles shifts after high-dose atorvastatin use in men with prostate cancer.
Raittinen P; Niemistö K; Pennanen E; Syvälä H; Auriola S; Riikonen J; Lehtimäki T; Ilmonen P; Murtola T
Sci Rep; 2020 Jul; 10(1):12016. PubMed ID: 32694638
[TBL] [Abstract][Full Text] [Related]
4. Simultaneous analysis of the total plasma concentration of atorvastatin and its five metabolites and the unbound plasma concentration of atorvastatin: Application in a clinical pharmacokinetic study of single oral dose.
Cestari RN; Rocha A; Marques MP; de Oliveira RDR; Lanchote VL
J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Sep; 1126-1127():121766. PubMed ID: 31450089
[TBL] [Abstract][Full Text] [Related]
5. Development and validation of a sensitive, simple, and rapid method for simultaneous quantitation of atorvastatin and its acid and lactone metabolites by liquid chromatography-tandem mass spectrometry (LC-MS/MS).
Macwan JS; Ionita IA; Dostalek M; Akhlaghi F
Anal Bioanal Chem; 2011 Apr; 400(2):423-33. PubMed ID: 21359569
[TBL] [Abstract][Full Text] [Related]
6. Atorvastatin induces adrenal androgen downshift in men with prostate cancer: A post Hoc analysis of a pilot adaptive Randomised clinical trial.
Raittinen PVH; Syvälä H; Tammela TLJ; Häkkinen MR; Ilmonen P; Auriola S; Murtola TJ
EBioMedicine; 2021 Jun; 68():103432. PubMed ID: 34144486
[TBL] [Abstract][Full Text] [Related]
7. Grape seed extract improved the fertility-enhancing effect of atorvastatin in high-fat diet-induced testicular injury in rats: involvement of antioxidant and anti-apoptotic effects.
Abdulwahab DK; Ibrahim WW; Abd El-Aal RA; Abdel-Latif HA; Abdelkader NF
J Pharm Pharmacol; 2021 Mar; 73(3):366-376. PubMed ID: 33793875
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of ezetimibe co-administered with atorvastatin in untreated patients with primary hypercholesterolaemia and coronary heart disease.
Blagden MD; Chipperfield R
Curr Med Res Opin; 2007 Apr; 23(4):767-75. PubMed ID: 17407633
[TBL] [Abstract][Full Text] [Related]
9. Atorvastatin calcium inclusion complexation with polysaccharide arabinogalactan and saponin disodium glycyrrhizate for increasing of solubility and bioavailability.
Kong R; Zhu X; Meteleva ES; Polyakov NE; Khvostov MV; Baev DS; Tolstikova TG; Dushkin AV; Su W
Drug Deliv Transl Res; 2018 Oct; 8(5):1200-1213. PubMed ID: 30039497
[TBL] [Abstract][Full Text] [Related]
10. The atorvastatin metabolic phenotype shift is influenced by interaction of drug-transporter polymorphisms in Mexican population: results of a randomized trial.
León-Cachón RBR; Bamford AD; Meester I; Barrera-Saldaña HA; Gómez-Silva M; Bustos MFG
Sci Rep; 2020 Jun; 10(1):8900. PubMed ID: 32483134
[TBL] [Abstract][Full Text] [Related]
11. Investigating the clinical factors and comedications associated with circulating levels of atorvastatin and its major metabolites in secondary prevention.
Turner RM; Fontana V; FitzGerald R; Morris AP; Pirmohamed M
Br J Clin Pharmacol; 2020 Jan; 86(1):62-74. PubMed ID: 31656041
[TBL] [Abstract][Full Text] [Related]
12. Atorvastatin plus omega-3 fatty acid ethyl ester decreases very-low-density lipoprotein triglyceride production in insulin resistant obese men.
Ng TW; Ooi EM; Watts GF; Chan DC; Barrett PH
Diabetes Obes Metab; 2014 Jun; 16(6):519-26. PubMed ID: 24299019
[TBL] [Abstract][Full Text] [Related]
13. A pilot window-of-opportunity study of preoperative fluvastatin in localized prostate cancer.
Longo J; Hamilton RJ; Masoomian M; Khurram N; Branchard E; Mullen PJ; Elbaz M; Hersey K; Chadwick D; Ghai S; Andrews DW; Chen EX; van der Kwast TH; Fleshner NE; Penn LZ
Prostate Cancer Prostatic Dis; 2020 Dec; 23(4):630-637. PubMed ID: 32203069
[TBL] [Abstract][Full Text] [Related]
14. P-glycoprotein has differential effects on the disposition of statin acid and lactone forms in mdr1a/b knockout and wild-type mice.
Chen C; Lin J; Smolarek T; Tremaine L
Drug Metab Dispos; 2007 Oct; 35(10):1725-9. PubMed ID: 17640956
[TBL] [Abstract][Full Text] [Related]
15. Comparative Effects of PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) Inhibition and Statins on Postprandial Triglyceride-Rich Lipoprotein Metabolism.
Chan DC; Watts GF; Somaratne R; Wasserman SM; Scott R; Barrett PHR
Arterioscler Thromb Vasc Biol; 2018 Jul; 38(7):1644-1655. PubMed ID: 29880491
[TBL] [Abstract][Full Text] [Related]
16. A Genome-wide Association Study of Circulating Levels of Atorvastatin and Its Major Metabolites.
Turner RM; Fontana V; Zhang JE; Carr D; Yin P; FitzGerald R; Morris AP; Pirmohamed M
Clin Pharmacol Ther; 2020 Aug; 108(2):287-297. PubMed ID: 32128760
[TBL] [Abstract][Full Text] [Related]
17. Long-term safety and tolerability profile of ezetimibe and atorvastatin coadministration therapy in patients with primary hypercholesterolaemia.
Ballantyne CM; Lipka LJ; Sager PT; Strony J; Alizadeh J; Suresh R; Veltri EP
Int J Clin Pract; 2004 Jul; 58(7):653-8. PubMed ID: 15311720
[TBL] [Abstract][Full Text] [Related]
18. Statin use and risk of disease recurrence and death after radical prostatectomy.
Keskiväli T; Kujala P; Visakorpi T; Tammela TL; Murtola TJ
Prostate; 2016 Apr; 76(5):469-78. PubMed ID: 26689439
[TBL] [Abstract][Full Text] [Related]
19. Obesity-related plasma hemodilution and PSA concentration among men with prostate cancer.
Bañez LL; Hamilton RJ; Partin AW; Vollmer RT; Sun L; Rodriguez C; Wang Y; Terris MK; Aronson WJ; Presti JC; Kane CJ; Amling CL; Moul JW; Freedland SJ
JAMA; 2007 Nov; 298(19):2275-80. PubMed ID: 18029831
[TBL] [Abstract][Full Text] [Related]
20. Use of statins and prostate cancer recurrence among patients treated with radical prostatectomy.
Chao C; Jacobsen SJ; Xu L; Wallner LP; Porter KR; Williams SG
BJU Int; 2013 May; 111(6):954-62. PubMed ID: 23464862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
